Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: a prospective longitudinal study

Gynecologic Oncology
Y M ChanL C Wong

Abstract

The purpose was to examine the outcomes of patients with advanced ovarian cancer treated with neoadjuvant chemotherapy, with a special emphasis on the patients' quality of life (QOL). Seventeen patients with advanced ovarian cancer were treated with neoadjuvant chemotherapy based on the extent of disease on computer tomography. All patients received combined platinum/paclitaxel chemotherapy. Debulking surgery was performed after three cycles or six cycles of chemotherapy, depending on the response to the chemotherapy. Patients' QOL was studied over time using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 and was then compared with that of patients treated with conventional treatment in the previous cohort. The response rate to chemotherapy assessed at three cycles was 82.4%. The rate of optimum debulking to residual disease less than 2 cm after chemotherapy was 76.9%, and 38.5% had no gross residual disease after surgery. The median overall survival was 22.9 months. The median disease-free interval was 13.3 months. The overall QOL improved after chemotherapy and this continued to improve up to 12 months. The other functional scales also showed improvements over time, apart from the...Continue Reading

Citations

Oct 3, 2003·Current Oncology Reports·Maria E L van der BurgUNKNOWN Gynecological Cancer Group of the EORTC
Apr 6, 2005·Oncology·Dimitrios PectasidesAnna Koumarianou
Sep 22, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·T LeM Fung Kee Fung
Jun 29, 2011·Revista do Colégio Brasileiro de Cirurgiões·Renato de Lima RozenowiczTsutomu Aoki
Jul 10, 2014·Journal of the National Cancer Institute·Kristine A DonovanLari Wenzel
Jan 10, 2016·The Cochrane Database of Systematic Reviews·Siriwan TangjitgamolAndrew Bryant
Nov 7, 2019·The Cochrane Database of Systematic Reviews·Sarah L ColeridgeJo Morrison
Jun 2, 2006·Obstetrics and Gynecology·Snehal Bhoola, William J Hoskins
Jul 24, 2004·Expert Review of Anticancer Therapy·Tjoung-Won Park, Walther C Kuhn
Aug 3, 2011·Expert Review of Anticancer Therapy·Takashi Onda, Hiroyuki Yoshikawa
Nov 30, 2010·Annals of Nuclear Medicine·Kazuhiro KitajimaKazuro Sugimura
Aug 31, 2010·Future Oncology·Dana M ChaseBradley J Monk
Dec 22, 2006·Nature Clinical Practice. Oncology·Charlotte C SunDiane C Bodurka
Oct 2, 2013·Journal of Obstetrics and Gynaecology of India·Sonia BatraKalpna S Dave
Oct 25, 2016·Obstetrics and Gynecology·UNKNOWN American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology
Feb 12, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Min-Hyun BaekJoo-Hyun Nam
Oct 19, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Yoshihiro NishiyamaMotoomi Ohkawa
Dec 6, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M Baekelandt
Aug 17, 2012·The Cochrane Database of Systematic Reviews·Jo MorrisonTheresa A Lawrie
Sep 24, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·San Soo HooSudha Sundar
Mar 7, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M-Y ChenT-C Chang
Feb 27, 2010·Journal of Surgical Oncology·Lori E WeinbergJean A Hurteau
Apr 11, 2008·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·I VergoteP Berteloot
Apr 1, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Dan ZhaoXiao-Guang Li
Oct 9, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jordan M CloydJohn F P Bridges
Feb 6, 2021·The Cochrane Database of Systematic Reviews·Sarah L ColeridgeJo Morrison
Apr 22, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Julie K SchwarzDominique Delbeke
Jun 3, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Amanda Canato FerraciniPriscila Gava Mazzola
Feb 23, 2010·World Journal of Surgical Oncology·Azam-Sadat MousaviSetareh Akhavan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC
T LeK Ward
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
K M McMasters, K K Hunt
© 2021 Meta ULC. All rights reserved